Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) Subsidiary Hejigong Pharmaceutical Factory's new production line and expanded production range have been approved.
Baiyunshan (600332.SH) issued an announcement that its subsidiary Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. ...
Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd., has received approval from the Guangdong Provincial Drug Administration for a "Drug Production License". The license allows Baiyunshan Pharmaceutical Holdings He Ji Gong Pharmaceutical Factory (referred to as "He Ji Gong pharmaceutical factory") to add new production lines and expand its production range, and pass the inspection for the Good Manufacturing Practice of pharmaceutical products. The factory is permitted to add a new production line for aerosols in the "Liwan Manufacturing Department" at its production address of 49 Liwan Road, Guangzhou, and expand its production range to include aerosols.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


